The NIAID is enrolling participants in its ACTT-4 clinical trial to assess the effectiveness of dexamethasone plus remdesivir, compared to baricitinib plus remdesivir.
The FDA issued an emergency use authorization for Regeneron's casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in patients 12 and older.
Mechanical ventilation is a life-saving technology, but the inevitable decision to wean a patient off of a ventilator requires a skillful combination of proven protocols, reliable technology, and teamwork between RTs and physicians.
SMTC Corporation will begin manufacturing Aura V ventilators for IPM Chirana, which also announced its US headquarters in North Carolina.
Beyond Air Inc will initiate a clinical study of its LungFit tankless nitric oxide (NO) system for evaluation of the safety and efficacy of high concentration inhaled NO given intermittently to adults hospitalized with acute viral pneumonia, including SARS-CoV-2.
A UArizona tele-ultrasound training program for lung point-of-care ultrasound will enable rural emergency departments to identify and treat suspected COVID-19 patients.
Respiratory compromise is the second leading avoidable patient safety issue in the US, with more than 60% of arrests classified as potentially avoidable.